Correlation Between Sunshine Biopharma and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunshine Biopharma and Eliem Therapeutics, you can compare the effects of market volatilities on Sunshine Biopharma and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Eliem Therapeutics.
Diversification Opportunities for Sunshine Biopharma and Eliem Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sunshine and Eliem is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Sunshine Biopharma and Eliem Therapeutics
Given the investment horizon of 90 days Sunshine Biopharma is expected to under-perform the Eliem Therapeutics. In addition to that, Sunshine Biopharma is 1.63 times more volatile than Eliem Therapeutics. It trades about -0.1 of its total potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 298.00 in Eliem Therapeutics on August 31, 2024 and sell it today you would earn a total of 6.00 from holding Eliem Therapeutics or generate 2.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.47% |
| Values | Daily Returns |
Sunshine Biopharma vs. Eliem Therapeutics
Performance |
| Timeline |
| Sunshine Biopharma |
| Eliem Therapeutics |
Sunshine Biopharma and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sunshine Biopharma and Eliem Therapeutics
The main advantage of trading using opposite Sunshine Biopharma and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Sunshine Biopharma vs. Shionogi Co Ltd | Sunshine Biopharma vs. China SXT Pharmaceuticals | Sunshine Biopharma vs. Shuttle Pharmaceuticals | Sunshine Biopharma vs. Lifecore Biomedical |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |